To access the abstract submission you must register as Corresponding Author using the link "Registration for abstracts submission" in the top menu. All communications will be sent to the email address specified at registration. Remember that the first author of the abstract or the presenter will necessarily have to be registered to the 8th EUROPEAN MYELOMA NETWORK MEETING.

Abstract should be submitted within 10 January 2027 (23:59).

When the abstract deadline has expired the Scientific Committee will evaluate the abstracts.

No. 8 best abstracts, selected by the reviewers among the best scored, will be selected for presentation as oral communication in plenary session.

EMN organizers offer no. 8 Travel Grants of € 500,00 each for clinical scientists of 40 years of age and below for best submitted abstracts. Only the presenting author is eligible.

Travel grants are awarded on the basis of scientific merit using the evaluation process of the Scientific Committee. Awardees are notified about the travel grant once their abstract has been evaluated. The grant is paid via bank transfer after the congress.

Notification of acceptance or rejection will be sent by e-mail to the corresponding author within 27 January 2027.

The electronic form will be arranged as follows:

• TOPIC ARGUMENT One from those:
1. Biology and preclinical
2. Newly diagnosed multiple myeloma
3. Relapsed/refractory multiple myeloma
4. Special conditions
• TITLE: First letter in upper case with all subsequent letters in lower case, except for those that must necessarily be written in upper case;
• ENCORE: Please indicate yes, if it's an encore abstract
• PROFESSIONAL POSITION: Professional or clinical appointment of the first author
  Please select one option from the following list: Full Professor, Associate Professor, Senior Consultant Physician, Consultant Physician, Research Fellow, Biologist, Laboratory Technician, Resident Physician, Research Grant Holder, Student;
• CONFLICT OF INTERESTS: Please specify any conflicts of interest of the first author according to the instructions that follow. Please indicate "No conflict" if not present, or the list of subjects with commercial interests in the health field with whom the first author has had relations, including financing, in the last two years. Please note that being in a situation of conflict of interest means owning shares in companies operating in the health field, being employed by them, royalties received from the same companies, but not having carried out studies, research or consultancy.
• AUTHORS: First author (ONLY the initial of the first name followed by the full surname), followed by all other authors in order of contribution (e.g. M. Rossi(1), G. Bianchi(1|2), A. Verdi(1); or, if all authors belong to a single institution, M. Rossi, G. Bianchi, A. Verdi). Authors must always be separated by a comma, with no final punctuation. Please note that this field is subject to automated validation and must follow the specified format exactly. The information entered will be processed as structured data, not as free text, and may be used to generate indexes and author listings;
• AUTHOR NOTES (optional): Use this field to specify equal contributions, shared first authorship, shared senior authorship, or other relevant authorship information. These notes will be included in the published abstract;
• AFFILIATIONS: Enter the participating institutions, separated exclusively by a semicolon (;) (e.g. (1)Pediatric Nephrology Unit, De Marchi Clinic; (2)Cardiology Unit I, Mangiagalli Clinic; (3)Ospedale Pediatrico Bambino Gesù or, if a single institution is involved, Pediatric Nephrology Unit, De Marchi Clinic). When multiple affiliations are listed, they must always be separated by a semicolon, with no final punctuation. Please note that this field is subject to automated validation. The information entered will be processed as structured data, not as free text.
  
  Please note that postal addresses, street names, and postal codes must not be included in the affiliation field. Such information is not required for scientific or editorial purposes and is therefore unnecessary. All correspondence will be handled exclusively via email through the designated corresponding author. Including address details may require manual editing and may introduce unintended errors;
CITY: Enter the city/cities of the institutions listed above, separated by a comma. When more than one city is indicated, each city must be prefixed with the same numerical identifiers used for the corresponding affiliations (e.g. (1|2)Milano IT, (3)Roma IT or, if a single institution is involved, Milano IT). City names must be entered in their original local language and must be followed by a hyphen (-) and the international country code (ISO 3166, 2 or 3 letter code). This field is subject to automated validation and must strictly follow the specified format;
• ABSTRACT TEXT: Plain text format only, with no formatting applied. Maximum 3,500 characters, including spaces. The system accepts accented characters, mathematical symbols, and Greek letters, but does not accept formatting styles such as bold, italic, superscript, or subscript. ^Superscript and _subscript characters, as well as bold, italic, and underline styles, may be applied exclusively via the dedicated popup menu located next to the labels of the Title and Abstract fields only. This menu allows the insertion of typographic tags that will be correctly interpreted by the system;
• CURRICULUM VITAE: after the abstract saving, you will be immediately requested to upload the Curriculum Vitae of the first author. Please prepare the .PDF file before filling out the abstract form;
• ATTACHED: Figures/tables are not mandatory. In any case, only one figure or table is allowed. Authors who wish to include one figure or table should first save the text of their abstract. Afterwards, from the detail page of the saved abstract, authors can access a form to attach one figure or one table only.